Skip to content

DEVANTHINIC PHARMA

Active Risk: not assessed Private limited companyfounded 2014active for 11 yearsRue des Canadiens 24, 7180 SeneffeKBO/BCE: BE 0506.893.294 #3 company by total assets in Seneffe, Administrative and support services sector
Heads the group DEVANTHINIC PHARMA 15 companies
See the group
DEVANTHINIC PHARMA
Financial year 2025
Follow ReportCompare

Annual accounts 2025

abbreviated format, filed on 27-08-2026, 27 days late
€7.7m
▲ 13.0%
€16.8m
▲ 0.8%
€888,590
▼ 9.6%
46.0%
▲ 5.0 percentage points
11.5%
▼ 2.9 percentage points
5.3%
▼ 0.6 percentage points

The turnover shown is an estimate from the gross margin.

Turnover ≈ €2.0m. Estimated: probably between €1.5m and €3.0m.

In the rankings #3 company by total assets in Seneffe, Administrative and support services sector#3 company by equity in Seneffe, Administrative and support services sector

Balance sheet

balance sheet total €16.8m on 31-12-2025
What the company ownsHow it is paid for

in €m

in euro

Position in the sector

Compare with sector

46.0%

Higher than 54% of 2,831 companies in 2025.

5.3%

Higher than 54% of 2,778 companies in 2025.

DEVANTHINIC PHARMA Middle half of the sector 80% of the sector Abbreviated accounts in office administrative support (NACE 82)

Net result: top quarter · Equity: top quarter · Balance sheet total: top quarter · Staff: top quarter

Staff

€51,369

Staff costs divided by the average number of full-time equivalents.

+6 people

people who joined people who left

In 2025, 8 people joined and 2 left.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20252024202320222021202020192018201720162015
Balance sheet: assets
20/58 16.8m16.7m15.6m14.4m14.0m9.6m8.1m7.5m6.2m4.8m910,075
21/28 14.2m14.2m13.8m12.6m12.6m8.4m7.0m7.0m6.0m4.8m904,277
22/27 34,7023,90616,53710,4275,74214,65229,30543,95758,610--
23 517128433739-------
24 34,1853,77816,1049,6895,74214,65229,30543,95758,610--
28 14.2m14.2m13.8m12.6m12.6m8.4m7.0m7.0m5.9m4.8m904,277
29/58 2.6m2.5m1.8m1.8m1.4m1.2m1.1m547,724221,65090,0145,798
40/41 2.2m2.0m1.5m1.4m1.1m1.1m646,560501,050196,27285,6121,464
40 699,425464,126243,340222,314315,335276,966178,325118,846123,67570,8391,464
41 1.5m1.6m1.3m1.2m786,980774,626468,234382,20472,59714,773-
54/58 351,359462,442213,315401,330285,56899,497449,19646,21325,3664,4024,334
490/1 1,882-17,40624,2203,90892347446111--
Balance sheet: equity and liabilities
10/49 16.8m16.7m15.6m14.4m14.0m9.6m8.1m7.5m6.2m4.8m910,075
10/15 7.7m6.8m5.9m5.2m3.5m2.6m1.9m1.5m274,460207,372165,676
10/11 150,000150,000150,000150,000150,000150,000150,000150,000150,000150,000150,000
100 ------150,000150,000150,000150,000150,000
13 997,250534,150260,50050,00050,00050,00050,00050,00050,00050,00011,300
130/1 15,00015,00015,00015,00015,00015,000-----
130 ------15,00015,00015,00015,0001,300
1311 15,00015,00015,00015,00015,00015,000-----
132 947,250484,150210,500--------
133 35,00035,00035,00035,00035,00035,00035,00035,00035,00035,00010,000
14 6.6m6.2m5.5m5.0m3.3m2.4m1.7m1.3m74,4607,3724,376
16 390,110209,091---------
160/5 390,110209,091---------
164/5 390,110209,091---------
17/49 8.7m9.6m9.8m9.2m10.5m6.9m6.2m6.0m6.0m4.6m744,399
17 6.3m7.5m8.0m7.7m8.3m5.6m1.7m1.9m1.1m450,507484,221
170/4 6.3m7.5m8.0m7.7m8.3m5.6m1.7m1.9m1.1m450,507484,221
42/48 2.3m2.1m1.8m1.5m2.2m1.4m4.5m4.1m4.9m4.2m260,178
42 594,027585,500563,524526,532477,629257,613182,287179,612112,28133,71433,146
43 ----4,70210,031-----
430/8 ----4,70210,031-----
44 171,97299,60351,36644,21115,478--34,87533,7681158,260
440/4 171,97299,60351,36644,21115,478--34,87533,7681158,260
45 72,526110,38543,07181,473102,97230,21042,73444,23747,81019,68111,598
450/3 10,90375,08218,27055,28493,59526,15842,73444,23747,81019,68111,598
454/9 61,62435,30324,80126,1899,3774,052-----
47/48 1.5m1.3m1.1m847,3041.6m1.1m4.2m3.9m4.7m4.1m207,173
Income statement
9900 1.3m1.4m1.2m1.2m930,157517,767379,220325,924273,327109,31334,196
62 431,503367,160284,874233,80268,07019,634-----
630 3,1071,3894,3892,73914,91014,65214,652178,20214,652--
635/8 181,018209,091---------
640/8 101868-04----
66A -243---------
9901 703,739818,903943,306970,758847,177483,481364,563147,721258,675109,31334,196
75/76B 610,000675,000110,0001.2m350,000460,000270,0001.3m0042
75 610,000675,000110,0001.2m350,000460,000270,0001.3m0042
65/66B 266,940331,380227,909181,708206,327178,555174,443172,277157,06142,3608,975
65 266,940331,380227,909181,708206,327178,555174,443172,277157,06142,3608,975
9903 1.0m1.2m825,3972.0m990,850764,926460,1201.3m101,61466,95325,263
780 ---1,650-------
67/77 158,208179,345183,447204,797165,76173,47652,85734,37734,52625,2579,587
9904 888,590983,178641,9511.8m825,089691,451407,2631.3m67,08841,69615,676
689 463,100273,650210,500--------
9905 425,490709,528431,4511.8m825,089691,451407,2631.3m67,08841,69615,676
Appropriation of the result
9906 6.6m6.2m5.5m5.0m3.3m2.4m1.7m1.3m74,46046,07215,676
14P 6.2m5.5m5.0m3.3m2.4m------
691/2 ---------38,70011,300
6920 ---------13,7001,300
6921 ---------25,00010,000
Social balance sheet
9087 8.46.764.91.30.5-----
Hours worked1013 10,0249,3437,7047,8542,270840-----
Document PDFPDFPDFPDFPDFPDFPDFPDFPDFPDFPDF

The notes to these accounts have 13 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 27-08-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank

2025 annual accounts filed 27 days after the deadline. Filed on 27 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00479392.

Financial year Type Filed Reference Document
31-12-2025 abbreviated format 27-08-2026 2026-00479392 PDF
31-12-2024 full format 29-08-2025 2025-00443740 PDF
31-12-2023 full format 26-08-2024 2024-00378500 PDF
31-12-2022 full format 31-07-2023 2023-00314109 PDF
31-12-2021 full format 26-08-2022 2022-20336846 PDF
31-12-2020 full format 30-08-2021 2021-57000316 PDF
31-12-2019 micro format 26-10-2020 2020-63400033 PDF
31-12-2018 micro format 09-09-2019 2019-63900157 PDF
31-12-2017 micro format 02-08-2018 2018-43300430 PDF
31-12-2016 full format 08-08-2017 2017-42800595 PDF
31-12-2015 full format 17-08-2016 2016-43800444 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20252024202320222021202020192018201720162015
44,601355,7311.2m7,4244.2m1.4m36,0021.2m1.3m3.9m904,277
-111,083249,127-188,016115,763186,071-349,699402,98320,84720,96468-
46.0%41.0%37.5%36.3%24.8%27.6%24.0%20.4%4.4%4.3%18.2%
11.5%14.4%11.0%33.6%23.8%26.2%20.9%82.2%24.4%20.1%9.5%
5.3%5.9%4.1%12.2%5.9%7.2%5.0%16.8%1.1%0.9%1.7%

EBIT margin: not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item31-12-202531-12-202431-12-202331-12-202231-12-2021
Employees at the balance-sheet date148753
full-time52232
part-time96521
in full-time equivalents10.86.364.52.8
8.46.764.91.3
On a permanent contract148753
Joined83-32
Left22-10
Training hours-13--10

Source: social balance sheet in the 2021 to 2025 annual accounts

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€33,902-€10,499€7,424€6,000
Financial fixed assets€10,699€355,731€1.2m-€4.2m
€3,107€1,389€4,389€2,739€14,910

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on DEVANTHINIC PHARMA

The operating result for 2025 is 14% lower than in 2024 and the lowest since 2020. It is the third fall in a row.

Debt's share of the balance-sheet total falls from 57.7% to 51.7%. Equity is higher and debt is lower.

Next steps

Work out how much credit to give this customer and on what payment terms.Credit check See what changed in the latest annual accounts.What changed

We would like to set cookies. That happens only with your consent. What we measure